Abstract:Carrot consumption reduces tumour development in several animal models, possibly as sources of polyacetylenes, resistant starch, carotenes or other active constituents. In a recent systematic review and meta-analysis of prospective studies (1) , we showed that carrot intake measured directly or using α-carotene as a marker of carrot intake was associated with reduced risk of cancer incidence. However, since the incidence of cancers among very old people (aged 85 and over) is lower than in those aged 65 to 85 (2) , it is of interest to understand how carrot intake affects cancer risk across different age groups. Here we compare the results from the Newcastle 85+ study 3 and a meta-analysis of prospective studies 1 of older adults aged 65-85 years at baseline. In the Newcastle 85+ study (3) (n = 387, 65% women), baseline dietary carrot intake was assessed using a multiple-pass recall tool (2×24 h recalls) and α-carotene concentration measured in plasma samples by reverse phase high-performance liquid chromatography. Cancer incidence data were ascertained from medical records, and the association between carrot intake and α-carotene and cancer risk (any type) tested using multivariable Cox proportional hazard regression models. For the meta-analysis (1) , mean ± SD of the reported upper age range at baseline in 50 studies (with 52000 cases) with data on carrot intake reported directly or indirectly (as α-carotene intake) was 68 ± 12 years, and in 30 studies (9331 cases) reporting plasma concentration of α-carotene it was 69 ± 9 years. In the Newcastle 85+ study, the summary risk ratio (RR) for cancer incidence was 0.82 (95% CI: 0.24 – 2.79, n = 129 cases, 258 non-cases) for consumption of ≥ 1 vs < 1 serving/day of carrots after adjusting for key confounders. RR for cancer for the highest compared with lowest quartile of plasma α-carotene was 0.68 (0.33 –1.39). The corresponding values comparing highest versus lowest exposure groups for the younger age groups in the meta-analysis (1) were: RRs (95% CI) for carrot intake 0·90 (0·87–0·94) and 0·80 (0·72–0·89) for plasma α-carotene. For most (67 of 80) of the individual studies included in the meta-analysis, the RRs were not statistically significantly different from 1, as was the case for the Newcastle 85+ study, due to small sample size and limited duration of the dietary records. However, the similarity of the RR values from the Newcastle 85+ study with the two corresponding independent datasets in the meta-analysis means that the results do not support a difference in effect between the age groups. The association of carrot consumption with incident cancer in the very old does not differ from younger age groups of older adults. Carrot consumption should be encouraged among the very old, and the causal mechanisms further investigated.

Effect of Beta- and Alpha-Carotene Intake on Tumour Formation in the Intestines of APCMin/+ Mice

Chemomodulatory Efficacy of Lycopene on Antioxidant Enzymes and Carcinogen-Induced Cutaneum Carcinoma in Mice

Association Between Intake Of Antioxidants And Pancreatic Cancer Risk: A Meta-Analysis

Effect of vegetable and carotenoid consumption on aberrant crypt multiplicity, a surrogate end-point marker for colorectal cancer in azoxymethane-induced rats

Carotenoid intake and esophageal cancer risk: a meta-analysis.

Association of Dietary Carrot/Carotene Intakes With Colorectal Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Beta-carotene Cancer Prevention Study

Dietary carotenoids and risk of breast cancer in Chinese women.

Resistant carbohydrates stimulate cell proliferation and crypt fission in wild-type mice and in the Apc(Min/+) mouse model of intestinal cancer, association with enhanced polyp development

Antrodia camphorata Supplementation during Early Life Alters Gut Microbiota and Inhibits Young-Onset Intestinal Tumorigenesis in APC1638N Mice Later in Life

beta-Carotene supplementation results in an increased serum and colonic mucosal concentration of beta-carotene and a decrease in alpha-tocopherol concentration in patients with colonic neoplasia

The Efficacy of Dietary Intake, Supplementation, and Blood Concentrations of Carotenoids in Cancer Prevention: Insights from an Umbrella Meta-Analysis.

β-carotene at physiologically attainable concentration induces apoptosis and down-regulates cell survival and antioxidant markers in human breast cancer (MCF-7) cells

Lycopene, beta-carotene, and colorectal adenomas

Phytic acid improves intestinal mucosal barrier damage and reduces serum levels of proinflammatory cytokines in a 1,2-dimethylhydrazine-induced rat colorectal cancer model

Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms

Association between carrot intake and cancer risk in a prospective observational study of >85-year-olds does not deviate from other age groups

Differential dietary effects on colonic and small bowel neoplasia in C57BL/6J Apc Min/+ mice

The Biochemical Effects of Carotenoids in Orange Carrots on the Colonic Proteome in a Mouse Model of Diet-induced Obesity

Carrot and Carotene and Multiple Health Outcomes: an Umbrella Review of the Evidence

Chemopreventive effects of berberine on intestinal tumor development in Apc min/+ mice